Diana Chira

Ms. Diana Chira

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Livia Livinț-PopaLivia Livinț-Popa
Livia Livinț-Popa
DCDiana Chira
Diana Chira
SSStefan Strilciuc
Stefan Strilciuc
Dafin Fior MuresanuDafin Fior Muresanu
Dafin Fior Muresanu
Traumatic brain injury (TBI) is a significant public health concern, often leading to long-lasting impairments in cognitive, motor and sensory functions. The rapid development of non-invasive systems has revolutionized the field of TBI rehabilitation by offering modern and effective interventions. This narrative review explores the application of non-invasive technologies, including electroencephalography (EEG), quantitative electroencephalography (qEEG), brain–computer interface (BCI), eye tracking, near-infrared spectroscopy (NIRS), functional near-infrared spectroscopy (fNIRS), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), magnetoencephalography (MEG), and transcranial magnetic stimulation (TMS) in assessing TBI consequences, and repetitive transcranial magnetic stimulation (rTMS), low-level laser therapy (LLLT), neurofeedback, transcranial direct current stimulation (tDCS), transcranial alternative current stimulation (tACS) and virtual reality (VR) as therapeutic approaches for TBI rehabilitation. In pursuit of advancing TBI rehabilitation, this narrative review highlights the promising potential of non-invasive technologies. We emphasize the need for future research and clinical trials to elucidate their mechanisms of action, refine treatment protocols, and ensure their widespread adoption in TBI rehabilitation settings.

1 March 2024 in Journal of Medicine and Life
Verified
Journal Article
Open access
DCDiana Chira
Diana Chira
OROlivia Verişezan Roşu
Olivia Verişezan Roşu
VCVlad-Florin Chelaru
Vlad-Florin Chelaru
DDDiana Chertic Dăbală
Diana Chertic Dăbală
LPLivia Livinț Popa
Livia Livinț Popa
FMFior Dafin Mureşanu
Fior Dafin Mureşanu
This secondary analysis of the CAPTAIN-RTMS trial data focused on the significance of quantitative electroencephalography (qEEG) indices as indicators of

29 October 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
SSStefan Strilciuc
Stefan Strilciuc
DCDiana Chira
Diana Chira
OROlivia Verisezan Rosu
Olivia Verisezan Rosu
OMOana Man-Kesselheim
Oana Man-Kesselheim
OSOana Stan
Oana Stan
Dafin Fior MuresanuDafin Fior Muresanu
Dafin Fior Muresanu
Background: Sleep is one of the most essential processes for sustaining cognitive, emotional, and physical health across all age groups. Insomnia or inadequate sleep significantly impacts health and poses economic burdens due to increased healthcare costs and reduced productivity. Objectives and Methods: This study aimed to investigate sleep quality in the Romanian active population using an online survey incorporating the Pittsburgh Sleep Quality Index (PSQI). Conducted over four months in 2023, the survey gathered 2243 complete responses from urban and rural residents over the age of 18. Results: The results highlight gender and urban–rural disparities in sleep quality, revealing that females and urban residents experienced poorer sleep compared to their counterparts. Additionally, sleep quality was found to significantly worsen with age, with elders (56+ years) reporting the highest PSQI scores, indicating greater sleep difficulties compared to middle-aged adults and youngsters. A high prevalence of sleep disturbances, daytime dysfunctions, and sleep medication use was reported. Common pre-sleep activities included using electronic devices and watching TV, while fewer participants engaged in reading books or consuming alcohol and caffeine. Additionally, participants’ bedding preferences were documented. Conclusions: Our study highlights the influence of various factors on sleep quality and emphasizes the need for targeted public health interventions to improve sleep health in Romania.

19 July 2023
Verified
Book Chapter
Open access
PDF file
LPLivia Livinț Popa
Livia Livinț Popa
DCDiana Chira
Diana Chira
AAAida Asaftei
Aida Asaftei
SSStefan Strilciuc
Stefan Strilciuc
DMDafin Mureșanu
Dafin Mureșanu
The hippocampus is a brain region that plays a vital role not only in learning and memory but also in a variety of cognitive processes. Additionally, the hippocampus is known for its plasticity or its ability to adapt structural and functional properties in response to internal and external factors. This plasticity is intricately modulated by a variety of factors, including neurotransmitters (such as glutamate), neurotrophic factors (such as BDNF, IGF-1, VEGFα, and NGF), cytokines, chemokines, adipokines (such as leptin and adiponectin), and hormones (such as cortisol, beta-endorphins, thyroid hormones, and noradrenaline). Changes in the number, length, type, and shape of dendritic spines within the hippocampus can influence neurotransmission, and subsequently behavior, through modulation of glutamatergic neurons. There are several interventions, including pharmacological treatments (such as antidepressants or multimodal drugs) and non-pharmacological interventions (such as non-invasive brain stimulation of targeted regions, physical exercise, and an enriched environment) that promote neurogenesis in the dentate gyrus, resulting in beneficial effects on cognition and mood. Both types of therapies have the potential to increase connectivity between the hippocampus and other areas of the brain involved in motor and cognitive control, and thus, improve performance in specific tasks.

28 September 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Dafin Fior MuresanuDafin Fior Muresanu
Dafin Fior Muresanu
OROlivia Verisezan Rosu
Olivia Verisezan Rosu
NJNicoleta Jemna
Nicoleta Jemna
IBIrina Benedek
Irina Benedek
JRJulia Rednic
Julia Rednic
SSStefan Strilciuc
Stefan Strilciuc
Background: Cognitive deficits following ischemic stroke significantly impair quality of life, highlighting the need for effective interventions. This study evaluates the efficacy and safety of extended N-Pep-12 dietary supplementation in enhancing cognitive recovery post-stroke. Methods: In this randomized, open-label, controlled study, 106 patients with supratentorial ischemic stroke were enrolled to receive either 90mg N-Pep-12 or no supplementation daily for 360 days and were followed-up for 360 days. Cognitive function and emotional well-being were assessed using established neuropsychological scales at baseline, 90 days, and 360 days post-stroke. Safety was monitored through adverse events and mortality rates. Results: Significant improvements were observed in the N-Pep-12 group compared to controls, particularly in the Montreal Cognitive Assessment scores at both 90 and 360 days, and in the Digit Symbol Coding scores at 360 days, suggesting enhanced cognitive recovery with extended N-Pep-12 supplementation. A linear regression for a composite outcome analysis at day 360 further confirmed the efficacy of N-Pep-12 in contributing to cognitive improvement. Safety profiles were favorable, with no significant adverse effects attributed to N-Pep-12. Conclusions: Extended dietary supplementation with N-Pep-12 appears to offer a safe and effective approach to support cognitive recovery in ischemic stroke survivors. These findings underscore the potential of the supplement as an add-on intervention for managing post-stroke cognitive impairments.

1 March 2024
Verified
Journal Article
Open access
VOVerişezan Roşu Olivia
Verişezan Roşu Olivia
DCDiana Chira
Diana Chira
VCVlad-Florin Chelaru
Vlad-Florin Chelaru
CDChertic Dăbală Diana
Chertic Dăbală Diana
LLLivinț Popa Livia
Livinț Popa Livia
FMFior Dafin Mureşanu
Fior Dafin Mureşanu
This secondary analysis of the CAPTAIN-RTMS trial data focused on the significance of quantitative electroencephalography (qEEG) indices as indicators of recovery in patients with traumatic brain injury (TBI). By focusing on the delta alpha ratio (DAR), delta theta/alpha beta ratio (DTABR), and theta beta ratio (TBR), this study explored the shifts in brainwave activity as a response to an integrative treatment regimen of repetitive transcranial magnetic stimulation (rTMS) combined with the neurotrophic agent Cerebrolysin. Findings revealed significant increases in DAR and DTABR, suggesting changes in neurophysiological dynamics after treatment. However, variations in TBR were inconclusive in providing clear electrophysiological insights. These results indicate that further research is necessary to describe and understand the underlying mechanisms of brain recovery and to develop refined treatment frameworks for patients with TBI.